Adverse event reporting of mirtazapine: A disproportionality analysis of FDA adverse event reporting system (FAERS) database from 2004–2024

• Keying Guo ,

  Contributed equally to this work with: Keying Guo, Haipeng Li

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology

  Affiliation College of Nursing, Bengbu Medical University, Bengbu, Anhui, People’s Republic of China

  https://orcid.org/0009-0000-0035-478X

  ⨯
• Haipeng Li ,

  Contributed equally to this work with: Keying Guo, Haipeng Li

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft

  Affiliation College of Mental Health, Bengbu Medical University, Bengbu, Anhui, People’s Republic of China

  ⨯
• Wei Wang,

  Roles Conceptualization, Formal analysis, Methodology

  Affiliation College of Nursing, Bengbu Medical University, Bengbu, Anhui, People’s Republic of China

  ⨯
• Ling Cheng,

  Roles Investigation

  Affiliation College of Nursing, Bengbu Medical University, Bengbu, Anhui, People’s Republic of China

  ⨯
• Weina Du,

  Roles Data curation

  Affiliation College of Nursing, Bengbu Medical University, Bengbu, Anhui, People’s Republic of China

  ⨯
• Jing Zhang

  Roles Supervision, Writing – review & editing

  * E-mail: mini0217@126.com

  Affiliation College of Mental Health, Bengbu Medical University, Bengbu, Anhui, People’s Republic of China

  https://orcid.org/0000-0002-5496-1574

  ⨯